Skip to main content
eScholarship
Open Access Publications from the University of California

UC Davis

UC Davis Electronic Theses and Dissertations bannerUC Davis

Synthesis and Evaluation of Atypical Psychoplastogens

Abstract

Neuronal atrophy is an underlying characteristic of neurodegenerative diseases and many mood disorders. Considering that the prevalence of these conditions has only continued to rise in recent decades, efficacious treatments are desperately needed. The discovery of psychoplastogens—a class of small molecules capable of rapidly promoting neuronal growth—has provided a foundation for the development of improved neurotherapeutics. My research objectives have been to utilize rational drug design to create psychoplastogens with novel pharmacological profiles, and to mitigate potential safety concerns of known psychoplastogens by engineering out unwanted off-target interactions and mitigating the potential for side effects. By combining the pharmacophores of psychoplastogens with those of inhibitors of a kinase implicated in the pathophysiology of neurogenerative diseases, I created a psychoplastogen that can address multiple hallmarks of Alzheimer’s and related diseases. Additionally, I conducted a structure–activity relationship study centered around the tropane core structure present in psychoplastogenic tropane alkaloids to discover novel psychoplastogenic tropanes with improved safety profiles and mitigated potential for side effects. Finally, I utilized a prodrug approach to design compounds capable of increasing endogenous levels of psychoplastogens. All told, the atypical psychoplastogens described herein are a step towards improved therapeutics for a number of disorders related to neuronal atrophy.

Main Content

This item is under embargo until December 13, 2030.